Abstract In 1994, an H7N2 subtype avian influenza virus of low pathogenicity was detected in live-bird markets (LBMs) of the Northeast United States. Since that time the H7N2 virus continues to circulate in the ,LBMs despite efforts to eradicate ,the virus by market closures followed by extensive cleaning and disinfection. Since 1996, the LBMs have been implicated as the ,source of virus in five outbreaks of H7N2 avian influenza in commercial poultry. Although the H7N2 virus is of low pathogenicity, several mutations have occurred at, or near, the cleavage site of the haemagglutinin (H) protein, a region of the protein known to influence pathogenicity of H5 and H7 avian influenza viruses. From 1994 to 2002, the amino-acid motif at the H cleavage site has gradually changed from PENPKTR/GLF to PEKPKKR/GLF, with the addition of two lysine (K) residues. Also, a 24-nucleotide deletion, believed to be part of the receptor-bindingregion, was first observed in LBM H7N2 isolates in 1996 and isseen in all isolates tested since 2000. These findings support the need to continue avian influenza virus (AIV) surveillance in the ,LBMs and to develop ,new ,and innovative methods ,to prevent ,the introduction of AIV into the LBMs and to find ways to eliminate it when it is detected. Live-bird markets (LBMs) have been intensely studied in recent ,years because avian influenza viruses in the markets are closely associated with avian influenza in commercial,poultry and ,the markets ,may ,serve as a ,‘fertile ground’ for virus mutations and emergence,of new influenza viruses with increased virulence or ability to infect other species, including humans. In1997, an H5N1 avian influenza virus (AIV) emerged in Hong Kong LBMs to infect 18 people; 6 of whom,died (Claas et al. 1998). The source of human infections was due to direct contact with infected chickens in the LBMs; there was no human-to- human,spread. Subsequent studies on the ,H5N1 virus showed ,that the virus most